Study shows one patient’s advanced breast cancer has been ‘eliminated’ using T-cell immunotherapy

Immunotherapy is an exciting area of research which in recent years has resulted in effective new treatments being made available for melanoma and...

4 June 2018

Letter suggests even more women may be affected by screening failure than previously thought

A new letter by researchers at King’s College London suggests that as many as 500,000 women may have not received their final invitations to the...

25 May 2018

Breast screening workforce will not be able to cope with backlog following crisis, unless urgently reinforced

The breast screening workforce does not have the capacity to absorb the thousands of catch-up mammograms required following the serious failure in...

15 May 2018

Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug

Findings could allow doctors to predict resistance and lead to changes in treatment New gene editing technique used to unearth mutation linked...

10 May 2018

Jules Peters makes a statement and speaks out against breast cancer to help raise money for vital research

Welsh rock star Jules Peters, along with Emeli Sande, Tallia Storm, Gaby Roslin, Jacquie Beltrao and Donna Fraser have joined forces to support...

9 May 2018

Campaigning for Perjeta Now in Scotland

For the many women who are living with secondary breast cancer what matters most is spending as much good quality time as they can with those they...

9 May 2018

Art for Cure returns with limited edition photos of David Bowie, Kate Moss, Jimi Hendrix and The Rolling Stones

Art for Cure will be held at the magnificent Glemham Hall, Suffolk, from Saturday 5 - Monday 7 May, from 10am-5pm. The exhibition is hoping to raise...

3 May 2018

A 'serious failure' has come to light in the national Breast Screening Programme in England

The Health Secretary, Jeremy Hunt, has made a statement to Parliament today about a 'serious failure' of the Breast Screening Programme in England....

2 May 2018

Carboplatin offers “long-awaited” advance on docetaxel chemotherapy for triple negative breast cancer patients who have BRCA mutations

Women with incurable ‘triple negative’ breast cancer who carry a BRCA mutation benefit more from a ‘platinum’ chemotherapy drug called carboplatin...

30 April 2018